I. Why Perform N-terminal Acetylation and C-terminal Amidation Modifications?

Chemically synthesized peptides often contain free amino and carboxyl groups. Since the peptide sequence typically corresponds to that of the parent protein, the peptide termini often need to be blocked—through N-terminal acetylation and C-terminal amidation—to more closely resemble the parent protein. These modifications reduce the overall charge of the peptide, decrease its solubility, and allow the peptide to mimic the original state of its α-amino and carboxyl groups as they exist within the parent protein.

II. What Are the Types of Peptide Modifications?

Peptide modifications are diverse and can be broadly categorized into post-synthetic modifications and process modifications (using derivatized amino acids for modification). Based on the modification site, they can also be classified into N-terminal modifications, C-terminal modifications, side-chain modifications, amino acid modifications, and backbone modifications.As an important means of altering the peptide backbone structure or side-chain groups, peptide modifications can effectively change the physicochemical properties of peptide compounds, enhance water solubility, prolong in vivo activity, alter biodistribution, eliminate immunogenicity, and reduce toxicity and side effects.

III. What Is the Optimal Peptide Length for Crosslinking?

A length of 10–15 residues is generally recommended for crosslinking. While longer peptides provide more regions for antibody recognition, they also have a higher tendency to form stable secondary structures, which may deviate from their native conformation. Excessively short peptides are usually ineffective unless there is a compelling justification, such as sequence homology with related protein family members or other proteins.

IV. What Are the Advantages of Peptide Antigens Compared to Natural Proteins?

Peptide antigens offer advantages over natural or recombinant proteins in terms of epitope enrichment, which enhances the stimulation of antibody production in the body. Synthetic peptide antigens are primarily used when natural antigens are difficult to extract, challenging to produce via recombinant expression, or when the protein antigen shares high homology with other proteins in the host, complicating antibody generation.

V. What are the common methods for peptide conjugation?

-SH conjugation (mediated by Sulfo-SMCC reagent, which requires adding a Cys at the N-terminus or C-terminus of the peptide to introduce a free -SH group) and -COOH/-NH₂ conjugation (crosslinking mediated by NHS/EDC or EDC). -SH conjugation enables precise and oriented coupling.

VI. How to dissolve and store peptides?

Most peptides are soluble in sterile PBS. For basic peptides, if they do not dissolve in PBS initially, try using 10% (or higher) acetic acid. If the peptide still does not dissolve, add a small volume (<1>

Lyophilized (powdered) peptides can be stored at -40°C for several years. Peptides in solution are far less stable than in lyophilized form—store solutions at neutral pH (pH 5-7) and -20°C, avoiding repeated freeze-thaw cycles.

VII. Precautions for Using Peptide Antigens in Immunization

The adjuvant and antigen must be thoroughly mixed, with the criterion for sufficient mixing being that the mixture remains homogeneous without layering after standing for an extended period. Each antigen requires approximately 1.5 mL, typically administered via subcutaneous immunization at four to five sites, with about 0.25 mL per site. The injection points should be spaced approximately 1–2 cm apart, as multi-point immunization aids in antigen absorption. During the immunization process, care should be taken to avoid puncturing blood vessels to prevent bleeding and infection.

VIII. What is the Protein Crosslinker SMCC?

Protein crosslinkers are a class of small-molecule compounds that possess two or more reactive ends targeting specific functional groups (e.g., -NH₂, -COOH, -SH, etc.). These crosslinkers can conjugate with two or more molecules separately, thereby linking them together to form conjugated proteins.

SMCC is a heterobifunctional crosslinker containing an N-hydroxysuccinimide (NHS) ester and a maleimide group. It can bridge compounds containing thiol (-SH) and amino (-NH₂) groups, respectively. This crosslinker is capable of penetrating the lipid bilayer of cell membranes. The NHS ester reacts with primary amines at pH 6.5–7.5 to form stable amide bonds, while the maleimide group forms stable thioether bonds with thiol groups.

KMD Bioscience offers standard linear peptides and provides customized modified peptide synthesis services tailored to clients' project requirements. Modified peptides are widely used in peptide drug research, immunology, diagnostics, biocatalysis, antibody modification, and peptide reagents.At KMD Bioscience, we offer a variety of peptide modification services, including C-terminal amidation, N-terminal acetylation, disulfide bond modification, and peptide labeling. For peptide conjugation, we primarily use BSA, KLH, and OVA as carrier proteins.Our peptide modification and conjugation services are supported by our technical experts' extensive experience and advanced technology, enabling us to meet diverse customer needs with high precision and reliability.

This article is intended for reference by scientific research enthusiasts. It cannot substitute for professional knowledge or practical experimental procedures that require more detailed and specialized information. If there is any copyright infringement, please contact the author immediately to remove the disputed material.